Australian Clinical Labs Ltd (AU:ACL) has released an update.
JPMorgan Chase & Co. and its affiliates have ceased to be substantial holders in Australian Clinical Labs Ltd, as detailed in a recent filing. This change in their financial interest involves voting securities and is linked to various transactions, including sales, purchases, and securities lending. The update comes after their last notification to the company on July 12, 2024, with the effective date of ceasing reported as July 22, 2024.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
